NL8203807A - Dioximino-cefalosporine-antibiotica. - Google Patents
Dioximino-cefalosporine-antibiotica. Download PDFInfo
- Publication number
- NL8203807A NL8203807A NL8203807A NL8203807A NL8203807A NL 8203807 A NL8203807 A NL 8203807A NL 8203807 A NL8203807 A NL 8203807A NL 8203807 A NL8203807 A NL 8203807A NL 8203807 A NL8203807 A NL 8203807A
- Authority
- NL
- Netherlands
- Prior art keywords
- group
- formula
- substituted
- carbon atoms
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/53—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30798381 | 1981-10-02 | ||
| US06/307,983 US4402955A (en) | 1981-10-02 | 1981-10-02 | Dioximino cephalosporin antibiotics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8203807A true NL8203807A (nl) | 1983-05-02 |
Family
ID=23192021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8203807A NL8203807A (nl) | 1981-10-02 | 1982-09-30 | Dioximino-cefalosporine-antibiotica. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4402955A (fr) |
| JP (1) | JPS5869888A (fr) |
| AU (1) | AU8891882A (fr) |
| BE (1) | BE894563A (fr) |
| DE (1) | DE3236065A1 (fr) |
| FR (1) | FR2514004B1 (fr) |
| GB (1) | GB2106905B (fr) |
| IL (1) | IL66888A0 (fr) |
| IT (1) | IT1157330B (fr) |
| NL (1) | NL8203807A (fr) |
| NZ (1) | NZ202034A (fr) |
| ZA (1) | ZA827133B (fr) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1582884A (en) * | 1977-05-19 | 1981-01-14 | Beecham Group Ltd | Clavulanic acid derivatives their preparation and use |
| DK330880A (da) * | 1979-08-03 | 1981-02-04 | Beecham Group Ltd | Fremgangsmaade til fremstilling af clavulansyrederivater |
| EP0053893B1 (fr) * | 1980-12-09 | 1985-03-20 | Beecham Group Plc | Dérivés de l'acide clavulanique, leur préparation et leur application |
| NZ199200A (en) * | 1980-12-23 | 1984-07-31 | Beecham Group Ltd | Clavulanic acid derivatives and pharmaceutical compositions |
| US4450270A (en) * | 1981-10-02 | 1984-05-22 | Eli Lilly And Company | Dioximino cephalosporin antibiotics |
| DE3247614A1 (de) * | 1982-12-23 | 1984-07-05 | Hoechst Ag, 6230 Frankfurt | Cephalosporinderivate und verfahren zu ihrer herstellung |
| DE3316797A1 (de) * | 1983-05-07 | 1984-11-08 | Hoechst Ag, 6230 Frankfurt | Verfahren zur herstellung von cephemverbindungen |
| DE3316798A1 (de) * | 1983-05-07 | 1984-11-08 | Hoechst Ag, 6230 Frankfurt | Verfahren zur herstellung von cephemverbindungen |
| US4703118A (en) * | 1985-04-08 | 1987-10-27 | Eli Lilly And Company | Synthesis of 3-iodomethyl cephalosporins |
| GB8519606D0 (en) * | 1985-08-05 | 1985-09-11 | Fujisawa Pharmaceutical Co | 3 7-d substituted-3-cephem compounds |
| US4749522A (en) * | 1985-10-31 | 1988-06-07 | Angio-Medical Corporation | Supercritical fluid extraction of animal derived materials |
| JP6151257B2 (ja) | 2011-09-09 | 2017-06-21 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | 肺内感染症の治療方法 |
| US8809314B1 (en) | 2012-09-07 | 2014-08-19 | Cubist Pharmacueticals, Inc. | Cephalosporin compound |
| US8476425B1 (en) | 2012-09-27 | 2013-07-02 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine compositions |
| US20140274993A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Ceftolozane-tazobactam pharmaceutical compositions |
| US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
| EP3100732A1 (fr) | 2013-03-15 | 2016-12-07 | Merck Sharp & Dohme Corp. | Compositions antibiotiques de ceftolozane |
| US10376496B2 (en) | 2013-09-09 | 2019-08-13 | Merck, Sharp & Dohme Corp. | Treating infections with ceftolozane/tazobactam in subjects having impaired renal function |
| US8906898B1 (en) | 2013-09-27 | 2014-12-09 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR63088B (en) * | 1976-04-14 | 1979-08-09 | Takeda Chemical Industries Ltd | Preparation process of novel cephalosporins |
| DE2714880A1 (de) * | 1977-04-02 | 1978-10-26 | Hoechst Ag | Cephemderivate und verfahren zu ihrer herstellung |
| JPS609719B2 (ja) * | 1977-08-06 | 1985-03-12 | 武田薬品工業株式会社 | セフアロスポリン誘導体およびその製造法 |
| IT1192287B (it) * | 1977-11-14 | 1988-03-31 | Fujisawa Pharmaceutical Co | Derivati di acido cefalosporanico ad azione farmaceutica e relativo procedimento di preparazione |
| AR228726A1 (es) * | 1978-05-26 | 1983-04-15 | Glaxo Group Ltd | Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato |
| GR75644B (fr) * | 1980-06-18 | 1984-08-02 | Fujisawa Pharmaceutical Co |
-
1981
- 1981-10-02 US US06/307,983 patent/US4402955A/en not_active Expired - Fee Related
-
1982
- 1982-09-29 NZ NZ202034A patent/NZ202034A/xx unknown
- 1982-09-29 JP JP57172485A patent/JPS5869888A/ja active Pending
- 1982-09-29 IL IL66888A patent/IL66888A0/xx unknown
- 1982-09-29 FR FR8216383A patent/FR2514004B1/fr not_active Expired
- 1982-09-29 DE DE19823236065 patent/DE3236065A1/de not_active Withdrawn
- 1982-09-29 ZA ZA827133A patent/ZA827133B/xx unknown
- 1982-09-29 GB GB08227760A patent/GB2106905B/en not_active Expired
- 1982-09-30 IT IT23566/82A patent/IT1157330B/it active
- 1982-09-30 NL NL8203807A patent/NL8203807A/nl not_active Application Discontinuation
- 1982-09-30 BE BE6/47729A patent/BE894563A/fr not_active IP Right Cessation
- 1982-09-30 AU AU88918/82A patent/AU8891882A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL66888A0 (en) | 1982-12-31 |
| IT8223566A0 (it) | 1982-09-30 |
| DE3236065A1 (de) | 1983-04-14 |
| NZ202034A (en) | 1985-09-13 |
| JPS5869888A (ja) | 1983-04-26 |
| FR2514004A1 (fr) | 1983-04-08 |
| IT1157330B (it) | 1987-02-11 |
| GB2106905A (en) | 1983-04-20 |
| AU8891882A (en) | 1983-04-14 |
| ZA827133B (en) | 1984-05-30 |
| US4402955A (en) | 1983-09-06 |
| BE894563A (fr) | 1983-03-30 |
| FR2514004B1 (fr) | 1986-04-18 |
| GB2106905B (en) | 1985-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL8203807A (nl) | Dioximino-cefalosporine-antibiotica. | |
| KR880001541B1 (ko) | 세팔로스포린 유도체의 제조방법 | |
| US4396620A (en) | Cephalosporin quinolinium betaines | |
| US4336253A (en) | Cephalosporin antibiotics | |
| US4396619A (en) | Cephalosporin betaines | |
| US4379787A (en) | Oximino-substituted cephalosporin compounds | |
| US4640919A (en) | 3-substituted carbacepem compounds having antibacterial effect | |
| US4692443A (en) | 3-bicyclicpyridinium-methyl cephalosporins | |
| CA1225390A (fr) | Cephalosporines 3-bicyclopyridinium-methyliques | |
| US4401668A (en) | Pyrazinium substituted cephalosporins | |
| US4450270A (en) | Dioximino cephalosporin antibiotics | |
| US4382932A (en) | Isoquinolinium substituted cephalosporins | |
| US4501739A (en) | Thieno and furopyridinium-substituted cephalosporins | |
| EP0248645A2 (fr) | Dérivés de céphalosporine | |
| US4748172A (en) | 3-bicyclicpyridinium-methyl cephalosporins | |
| CS204957B2 (en) | Method of producing novel 7-2-/4-thiazolyl/-2-iminoacetamido-3-/4-alkyl-5-oxo-6-hydroxy-4,5-dihydro-1,2,4-triazin-3-ylthio/methyl-3-cephemderivatives | |
| US4388316A (en) | Amino-substituted oxazole, oxadiazole and isoxazole-substituted cephalosporins | |
| US4382931A (en) | 3'-Substituted quinolinium cephalosporins | |
| EP0238061A2 (fr) | Dérivés de céphalosporine, procédés pour leur préparation et agents antibactériens | |
| US4117125A (en) | 7-Acylamino-3-[1-[2-(carboxymethylamino]ethyl) tetrazol-5-ylthiomethyl]-3-cephem-4-carboxylic acids | |
| CA1174668A (fr) | Agents antibiotiques a base de cephalosporine bis- tetrazoylmethylee | |
| EP0045717B1 (fr) | Dérivés de céphalosporine, leur préparation et leur application | |
| US4088761A (en) | 3-[(1,3-Dithiin-5-yl)-acetamido]-cephalosporins and antibacterial compositions containing them | |
| US4034088A (en) | Cephalosporin derivatives, and compositions containing them | |
| GB2177691A (en) | Cephalosporin antibiotics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A85 | Still pending on 85-01-01 | ||
| BV | The patent application has lapsed |